Breaking News

PharmaForm Signs Formulation Services Pact

Akela Pharma's wholly owned subsidiary, PharmaForm, has signed a development agreement with an undisclosed global pharmaceutical company, to develop specialized oral dosage forms at its Austin, TX facility.

Akela Pharma’s wholly owned subsidiary, PharmaForm, has signed a development agreement with an undisclosed global pharmaceutical company, to develop specialized oral dosage forms at its Austin, TX facility.

Under the terms of the agreement, PharmaForm will provide contract formulation services to develop products in one or more therapeutic areas using its expertise in hot melt extrusion. PharmaForm will be entitled to royalty payments upon product commercialization.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters